Market Overview:
The global advanced drug delivery systems market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in the field of drug delivery systems. Based on type, the global advanced drug delivery systems market is segmented into oral drug delivery, pulmonary drug delivery, transdermal drug delivery, and parenteral drug delivery. Oral Drug Delivery dominates this market with a share of more than 50%. This can be attributed to factors such as ease-of-use and lower costs as compared to other modes of administration. However, pulmonary Drug Delivery is expected to grow at a higher CAGR during the forecast period owing to its advantages such as improved patient compliance and reduced side effects. Based on application, hospitals account for majority share in this market followed by specialized clinics and clinical research & development centers respectively. Hospitals are majorly used for treatment purposes; hence they hold a larger share in this segment than other applications segments.
Product Definition:
An advanced drug delivery system is a system that improves the effectiveness of drugs by controlling their release and absorption into the body. This can include using new technologies to target drugs to specific areas of the body, or releasing them in a controlled manner so they are released over time. The importance of advanced drug delivery systems is that they can improve the effectiveness of drugs, which can lead to better treatment outcomes for patients.
Oral Drug Delivery:
Oral drug delivery is a process of delivering drugs to patients without the help of injections. The oral route of drug administration is an ancient technique, which has evolved with time and technology into modern techniques such as controlled release dosage forms and implants.
The global market for oral drug delivery systems was valued at over USD 49 billion in 2015 and it is expected to grow at a CAGR close to 4% during the forecast period.
Pulmonary Drug Delivery:
Pulmonary drug delivery is the process of transporting drugs to the lungs. Pulmonary drug delivery system includes devices that are used to deliver drugs for treating chronic respiratory diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and pulmonary hypertension.
The global market for pulmonary drug delivery has witnessed significant growth in recent years owing to increasing prevalence of respiratory disorders such as asthma, COPD, and lung cancer which require efficient treatment methods.
Application Insights:
Based on application, the market is segmented into hospitals, specialized clinics, clinical research & development centers and others. Hospitals held the largest share in 2017 owing to factors such as increasing prevalence of chronic diseases and aging population. Moreover, an increase in hospital-acquired pharmaceutical products for providing advanced care is also expected to contribute towards segment growth during the forecast period.
The specialized clinics are anticipated to witness lucrative growth over the forecast period due to factors such as growing preference for minimally invasive procedures and technological advancements that enhance drug delivery efficiency. For instance, a recent advancement by Intellihot¢â‚¬â„¢s developers has enabled real-time 3D imaging of blood flow through heat mapping which can be used for targeted drug delivery at a cellular level using gene therapy vector systems or antibody drugs via transdermal or intracutaneous routes respectively.
Regional Analysis:
North America dominated the global market in 2017 owing to factors such as favorable reimbursement policies, increasing geriatric population, and rising incidences of cancer & cardiovascular diseases. Moreover, an increase in R&D investments by pharmaceutical companies is expected to drive the growth of this regional market over the forecast period. The U.S.-based companies are engaged in extensive research activities for developing advanced drug delivery systems for treatment of various disorders and conditions such as diabetes & obesity (in-vitro), Multiple Sclerosis (in-vivo) and Pulmonary Embolism (in-vitro).
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to factors such as improving healthcare infrastructure coupled with growing target disease population especially in emerging countries like China & India that are majorly driven by their high unmet medical needs resulting into increased adoption rate of these systems across hospitals & specialized clinics thereby driving demand across this region.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyle and dietary habits of people across the world. According to a study by the World Health Organization (WHO), non-communicable diseases such as cancer, cardiovascular disease, diabetes, and respiratory disorders are responsible for 63% of all deaths worldwide. This provides a huge opportunity for advanced drug delivery systems that can help in delivering drugs directly to the affected tissues or organs.
- Growing demand for targeted therapies: The traditional approach to drug therapy involves administering drugs indiscriminately into the body with the hope that they will reach and treat the target tissue or organ. However, this approach often leads to adverse side effects due to systemic exposure to high levels of medication. In contrast, targeted therapies involve delivering drugs directly to the target tissue or organ using advanced drug delivery systems such as nanoparticles and microspheres. This helps in minimizing adverse side effects while achieving better therapeutic outcomes.
Scope Of The Report
Report Attributes
Report Details
Report Title
Advanced Drug Delivery Systems Market Research Report
By Type
Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery
By Application
Hospitals, Specialized Clinics, Clinical Research & Development Centers
By Companies
NeXstar Pharmaceuticals, West Pharmaceutical Services, AstraZeneca, Sequus Pharmaceuticals, 3M, Novartis International
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
150
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Advanced Drug Delivery Systems Market Report Segments:
The global Advanced Drug Delivery Systems market is segmented on the basis of:
Types
Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialized Clinics, Clinical Research & Development Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- NeXstar Pharmaceuticals
- West Pharmaceutical Services
- AstraZeneca
- Sequus Pharmaceuticals
- 3M
- Novartis International
Highlights of The Advanced Drug Delivery Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Drug Delivery
- Pulmonary Drug Delivery
- Transdermal Drug Delivery
- Parenteral Drug Delivery
- By Application:
- Hospitals
- Specialized Clinics
- Clinical Research & Development Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Advanced Drug Delivery Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Advanced Drug Delivery Systems (ADDS) are a class of drug delivery devices that can improve the efficacy and safety of drugs by increasing their speed, accuracy, and distance from the target site. ADDS can be divided into two categories: active and passive. Active ADDS devices use energy to break down barriers between drugs and cells, while passive ADDS devices rely on physical forces to move drugs through tissues.
Some of the major players in the advanced drug delivery systems market are NeXstar Pharmaceuticals, West Pharmaceutical Services, AstraZeneca, Sequus Pharmaceuticals, 3M, Novartis International.
The advanced drug delivery systems market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Advanced Drug Delivery Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Advanced Drug Delivery Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Advanced Drug Delivery Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Advanced Drug Delivery Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Advanced Drug Delivery Systems Market Size & Forecast, 2018-2028
4.5.1 Advanced Drug Delivery Systems Market Size and Y-o-Y Growth
4.5.2 Advanced Drug Delivery Systems Market Absolute $ Opportunity
Chapter 5 Global Advanced Drug Delivery Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Advanced Drug Delivery Systems Market Size Forecast by Type
5.2.1 Oral Drug Delivery
5.2.2 Pulmonary Drug Delivery
5.2.3 Transdermal Drug Delivery
5.2.4 Parenteral Drug Delivery
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Advanced Drug Delivery Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Advanced Drug Delivery Systems Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialized Clinics
6.2.3 Clinical Research & Development Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Advanced Drug Delivery Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Advanced Drug Delivery Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Advanced Drug Delivery Systems Analysis and Forecast
9.1 Introduction
9.2 North America Advanced Drug Delivery Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Advanced Drug Delivery Systems Market Size Forecast by Type
9.6.1 Oral Drug Delivery
9.6.2 Pulmonary Drug Delivery
9.6.3 Transdermal Drug Delivery
9.6.4 Parenteral Drug Delivery
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Advanced Drug Delivery Systems Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialized Clinics
9.10.3 Clinical Research & Development Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Advanced Drug Delivery Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Advanced Drug Delivery Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Advanced Drug Delivery Systems Market Size Forecast by Type
10.6.1 Oral Drug Delivery
10.6.2 Pulmonary Drug Delivery
10.6.3 Transdermal Drug Delivery
10.6.4 Parenteral Drug Delivery
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Advanced Drug Delivery Systems Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialized Clinics
10.10.3 Clinical Research & Development Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Advanced Drug Delivery Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Advanced Drug Delivery Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Advanced Drug Delivery Systems Market Size Forecast by Type
11.6.1 Oral Drug Delivery
11.6.2 Pulmonary Drug Delivery
11.6.3 Transdermal Drug Delivery
11.6.4 Parenteral Drug Delivery
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Advanced Drug Delivery Systems Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialized Clinics
11.10.3 Clinical Research & Development Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Advanced Drug Delivery Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Advanced Drug Delivery Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Advanced Drug Delivery Systems Market Size Forecast by Type
12.6.1 Oral Drug Delivery
12.6.2 Pulmonary Drug Delivery
12.6.3 Transdermal Drug Delivery
12.6.4 Parenteral Drug Delivery
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Advanced Drug Delivery Systems Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialized Clinics
12.10.3 Clinical Research & Development Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Advanced Drug Delivery Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Advanced Drug Delivery Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Advanced Drug Delivery Systems Market Size Forecast by Type
13.6.1 Oral Drug Delivery
13.6.2 Pulmonary Drug Delivery
13.6.3 Transdermal Drug Delivery
13.6.4 Parenteral Drug Delivery
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Advanced Drug Delivery Systems Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialized Clinics
13.10.3 Clinical Research & Development Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Advanced Drug Delivery Systems Market: Competitive Dashboard
14.2 Global Advanced Drug Delivery Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 NeXstar Pharmaceuticals
14.3.2 West Pharmaceutical Services
14.3.3 AstraZeneca
14.3.4 Sequus Pharmaceuticals
14.3.5 3M
14.3.6 Novartis International
